CSE:AGRA | Frankfurt: PU31 | OTC: AGFAF

Agraflora-full_logo-green

Home
About
Brands
Distribution
- Farmako
Investors
- Investor Information
- News

Brands
Investors
News
Contact

CONTACT AGRAFLORA

AgraFlora

Suite 810 – 789 West Pender Street
Vancouver, BC, V6C 1H2

ir@agraflora.ca
(800) 783-6056

Leave Us a Message

Name

Email Address

Message

13 + 11 =

Sign up for our newsletter

In just a couple quick steps, you can sign up to get our latest updates.

You have Successfully Subscribed!

Agraflora-full_logo-green-2

AGRAFLORA
Home
About
Brands
Investors
Contact

LATEST NEWS

AgraFlora Announces Farmako Supply Agreement of Proprietary THC Testkits to STADAPHARM

Apr 12, 2021

AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) (FRA:PU31) CEO Elise Coppens told shareholders the “transformational sale” of two of its assets provided the company with the financial flexibility to look at entering more lucrative markets.

AgraFlora Organics CEO says recent asset sales give ‘us the financial flexibility’ to enter lucrative markets

Apr 8, 2021

AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) (FRA:PU31) CEO Elise Coppens told shareholders the “transformational sale” of two of its assets provided the company with the financial flexibility to look at entering more lucrative markets.

AgraFlora and Other Owners Agree to Sell Edibles Business for $35 Million to Organigram

Apr 6, 2021

Vancouver, British Columbia / April 6, 2021 (Globe Newswire) – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that it and its fellow shareholders have entered into an agreement to sell The Edibles & Infusions Corporation (“EIC”), an entity of which AgraFlora owns 43%, to Organigram Holdings Inc.

COPYRIGHT BY AGRAFLORA – 2019